sequence under fasting conditions and at least 2 weeks washout period between the doses.,A randomized&#44

A Bioequivalence study of a randomized, open-label, single-dose, two-way crossover design with two-period, two-treatment and two-sequence of Rosuvastatin tablets (20 mg) relative to Crestor 20 mg tablet® in healthy Thai volunteers under fasting condition.

A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Ezetimibe Tablet (10 mg) relative to EzetrolTM 10 mg in healthy Thai volunteers under fasting condition